Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00465764 · ClinicalTrials.gov registry record · Phase 2

Tolerance and Development of Healthy, Term Infants

A Phase 2 study of Healthy, sponsored by Abbott Nutrition.

Completed
Registry status
Phase 2
Development phase
115
Enrollment target
2
Study locations

NCT00465764 is a Phase 2 study of Healthy that has completed, run by Abbott Nutrition. The registered enrollment target is 115 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (82% lower). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00465764, a Phase 2 study of Healthy, has completed, sponsored by Abbott Nutrition.

COMPLETED
Registry status
Phase 2
Development phase
115 participants
Enrollment target
2
Study locations

Study Summary

To compare the tolerance and early bone status of healthy, term infants fed formulas during the first three months of life.

Conditions Studied

Healthy

Interventions

  • OTHER Alternate protein infant formula
  • OTHER Standard infant formula

Study Locations (2)

Nebraska

  • Midwest Children's Health Research Institute - Lincoln

Texas

  • Children's Nutrition Research Center, Baylor College of Medicine - Houston

Trial Details

FieldValue
Enrollment Target 115 participants
Start Date 2007-04
Est. Completion 2008-06
Phase Phase 2

Sponsor

Abbott Nutrition

89 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00465764

The ClinicalTrials.gov registry entry for NCT00465764 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 115 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (82% lower). The listed sponsor is Abbott Nutrition, which has 89 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Healthy appearing as the primary indexed condition, and to 2 interventions - of which Alternate protein infant formula is the first listed.

NCT00465764 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Nebraska, Texas.

Frequently Asked Questions

What is clinical trial NCT00465764 about?

NCT00465764 is a clinical study titled "Tolerance and Development of Healthy, Term Infants". To compare the tolerance and early bone status of healthy, term infants fed formulas during the first three months of life.

What is the current status of trial NCT00465764?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 115 participants. The study started on 2007-04. Estimated completion is 2008-06.

What conditions does trial NCT00465764 study?

This clinical trial studies the following conditions: Healthy.

What interventions are being tested in trial NCT00465764?

The interventions under investigation include: Alternate protein infant formula (OTHER), Standard infant formula (OTHER).

Who is sponsoring clinical trial NCT00465764?

This trial is sponsored by Abbott Nutrition, which has 89 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00465764 being conducted?

This trial has 2 study locations across Nebraska, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Healthy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Healthy

All registered trials for this condition

Nebraska

All trials with a study site in Nebraska

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.